2023. Inflammasomes as a Prognostic Marker and Possible Therapeutic Target in Multiple Sclerosis: A Rapid Review of the Literature. Principles and Practice of Clinical Research. 9, 2 (Sep. 2023). DOI:https://doi.org/10.21801/ppcrj.2023.92.7.